Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation.
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: alvaro.alonso@emory.edu.
Alvaro
A
Alonso
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Pamela L
PL
Lutsey
Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
Lin Y
LY
Chen
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Richard F
RF
MacLehose
Health Economics and Outcomes Research, Life Sciences, Optum, Eden Prairie, MN, USA.
Lindsay G S
LGS
Bengtson
D000925:Anticoagulants; D001281:Atrial Fibrillation; D000069604:Dabigatran; D006801:Humans; D014859:Warfarin; D015091:beta-Alanine
D000925:Anticoagulants; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran
Anticoagulation; Atrial fibrillation; Comparative effectiveness